The most commonly used serum biomarker for ovarian cancer is CA 125 (Carcinoma antigen 125, also known as mucin 16 or MUC16), which was initially used to monitor ovarian cancer patients during therapy. The gene discussed is MUC16; the disease is ovarian cancer.